The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus.
about
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domainsHepatitis C virus relies on lipoproteins for its life cycleChronic hepatitis C virus infection and lipoprotein metabolismGenetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignImpact of lipids and lipoproteins on hepatitis C virus infection and virus neutralizationApolipoprotein C1 Association with Hepatitis C VirusTargeting host factors: A novel rationale for the management of hepatitis C virusThe autophagy machinery is required to initiate hepatitis C virus replicationIdentification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C VirusApolipoprotein E but Not B Is Required for the Formation of Infectious Hepatitis C Virus ParticlesAmphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral EntryNaturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralizationThe missing pieces of the HCV entry puzzle.Identification of treatment efficacy-related host factors in chronic hepatitis C by ProteinChip serum analysisRegulated Entry of Hepatitis C Virus into Hepatocytes.Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes.Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation.Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agentsThe Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome.Amphipathic α-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particlesProduction of hepatitis C virus lacking the envelope-encoding genes for single-cycle infection by providing homologous envelope proteins or vesicular stomatitis virus glycoproteins in trans.Hepatitis C virus attenuates mitochondrial lipid β-oxidation by downregulating mitochondrial trifunctional-protein expression.Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion.Targeting host lipid synthesis and metabolism to inhibit dengue and hepatitis C viruses.Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.Early steps of the hepatitis C virus life cycle.The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.Role of lipid metabolism in hepatitis C virus assembly and entry.Immunotherapeutic potential of neutralizing antibodies targeting conserved regions of the HCV envelope glycoprotein E2.Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation.Hepatitis C virus evasion mechanisms from neutralizing antibodiesLipoprotein receptors and lipid enzymes in hepatitis C virus entry and early steps of infection.Incorporation of hepatitis C virus E1 and E2 glycoproteins: the keystones on a peculiar virion.Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps.Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles.Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design.Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry
P2860
Q21089621-43F5C360-6016-4657-8C3E-55426A3DE075Q26766119-7C2763AE-7617-4EE0-9DFF-59EE5F9ED2A4Q26784234-6F81AFE6-3EC0-415B-A150-94955C5FDBC6Q26801759-8DB208BE-C846-4A57-8D92-F6994DFD3F99Q26864485-99533A5B-CF65-43EA-AFE2-9E784ED7D59EQ27486923-61AF6748-E871-41E0-AAAD-FA3604E48945Q27488999-661F013C-F5AC-4C28-8074-AB7892413F03Q27489377-6B8057B6-ABDF-44B9-B09A-492DDFAD8A5AQ27490467-8952DA1D-E331-41AA-8A68-290254E40770Q27490474-FFD4F5CC-F2D5-47BF-87B5-FCBA50B67417Q27490785-3B7F0BCE-206A-4742-A903-BA5E85606C57Q28731355-DA312E5F-138A-47D5-B942-20ADD4EBB8A6Q33360674-5A91ED52-D34A-42C4-8DFA-B6077FF8FC5CQ33712188-FEAA75B8-EE37-46A2-8299-DE2ECFB22794Q33753913-ABBE22B3-58FE-4F15-A7A2-BEC4FDC4EBB0Q33877342-D980CCB0-9BAD-47EA-A7C2-7339F50025A1Q34000124-52AE06BB-0D33-4652-AD4C-8912D13E9CD2Q34416004-496C96A4-BA90-4D10-BAC5-5C8337B46490Q34481429-1D7E7D0E-E9F2-42D7-93F2-AB130F4AA91BQ34509568-4B96D970-2F78-415F-87D3-DE27740A9E68Q34682186-3CCBB989-C4FF-475A-AB72-F8B9E9597792Q34741763-6785A697-BAC8-403A-BF9D-9BDBC5A4ABCFQ35641048-F66B564F-CA96-4BCD-BA85-59237A7C1DE9Q36318779-9F56E870-C0B9-4731-B27E-F0178FD9D884Q36425870-DEC5CD01-0B39-4F66-A843-0975AF7D0A2AQ37015738-66860047-6ADE-47CA-BF11-E8A2608A0F5CQ37032802-5C4D6050-4382-48A2-AF45-EC03232ED76EQ37609487-D8B63862-C9C0-4AD4-B4E5-A58083B83C3FQ37621569-65D8F255-77E9-4580-A9B0-FB30946E8199Q37859393-282D2FDC-66BB-47A9-9964-FC12544B92E3Q37864742-25EF23C6-8C75-4A97-9A64-DC0090A94E03Q37967737-C57540DC-0342-4D38-B6C2-FC48E1C5F721Q38166372-313F5A61-7FD5-4752-922F-828A207DCB75Q38195180-876C2934-4683-41BD-A943-33D778AD3817Q39318833-69C75F3A-C3D7-4F7A-ADD4-5F2B66926A0DQ39380623-C1F0F79E-0703-4C0F-8786-5CA041D901BBQ40348492-C084E07B-35E8-4F80-BDD7-649BD50968EDQ42981153-01A44578-1EE2-404E-BC93-3D491E9A9280Q55513556-AED4B176-FA35-43A4-A523-3F8F30C55F1CQ57490859-C53EC908-821A-413D-BFDB-A663204DE553
P2860
The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus.
@en
type
label
The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus.
@en
prefLabel
The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus.
@en
P2093
P2860
P50
P356
P1476
The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus
@en
P2093
Eve-Isabelle Pécheur
Jennifer Molle
Sylvie Ricard-Blum
P2860
P304
32357-32369
P356
10.1074/JBC.M705358200
P407
P577
2007-08-30T00:00:00Z